Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > preliminary short form prospectus
View:
Post by spesestsemper on Jul 18, 2024 3:19pm

preliminary short form prospectus

There is a new filing on sedar dated july 12th for 150 million .

here is an excerpt of outstanding shares

Authorized Capital Our authorized capital consists of an unlimited number of Common Shares. The following is a summary of the provisions attached to our Common Shares. Common Shares The holders of our Common Shares are entitled to one vote per share at meetings of shareholders, to receive such dividends as declared by the Board and to receive our remaining property and assets upon dissolution or wind up. Our Common Shares are not subject to any future call or assessment and there are no pre-emptive, conversion or redemption rights attached to such shares. As at the date hereof, we have 76,986,033 Common Shares issued and outstanding. After giving effect to the exercise of all outstanding options to acquire Common Shares granted under the Corporation’s stock option plan and the vesting of all outstanding share awards granted under the Corporation’s share award plan, we would have 84,595,868 Common Shares issued and outstanding. Common Share Purchase Warrants As of the date hereof, we have 64,035 Common Share purchase warrants (the “2019 Warrants”) issued and outstanding. Each 2019 Warrant entitles the holder to purchase one common share at an exercise price of US$0.90 until August 16, 2024. As of the date hereof, we have 7,667,050 Common Share purchase warrants (the “2023 Warrants”) issued and outstanding. Each 2023 Warrant entitles the holder to purchase one common share at an exercise price of US$2.81 until August 8, 2028. As of the date hereof, we have 536,693 Common Share purchase warrants (the “2023 Compensation Warrants”) issued and outstanding. Each 2023 Compensation Warrant entitles the holder to purchase one common share at an exercise price of US$2.25 until August 8, 2028.
Comment by spesestsemper on Jul 18, 2024 3:22pm
Search (sedarplus.ca)
Comment by spesestsemper on Jul 18, 2024 3:24pm
I can only hope this is setup for a partner buy in and it won't be used until the share price is much higher .
Comment by Noteable on Jul 18, 2024 3:30pm
This is just a 2 year renewal of the same $150 Million short form prospectus that has been repeatedly filed with the last expiring on July 12, 2024. Find the last one yourself. From ONCY's December 2021 management discussion" "On June 12, 2020, we renewed our short form base shelf prospectus (the "Base Shelf") that qualifies for distribution of up to $150 million of ...more  
Comment by spesestsemper on Jul 18, 2024 3:35pm
Thats good then - just came up . The clock is ticking for christophe to bring home the bacon . time is of the essence . I dont know about anyone else but my clock is almost done . If nobody is interested in the company in the next little bit - do they really have anything to sell ? I'm doubting roche is even in the picture except maybe as a supplier .
Comment by Buckhenry on Jul 18, 2024 3:48pm
When the posting here started focusing on politics instead of the company... that should send a big red flag to everyone.  Folks on here don't know jack squat about either topic. 
Comment by Noteable on Jul 18, 2024 3:49pm
spesestemper arrived on this message board on April 18, 2024. and has been pumping ONCY's new hire.That in itself says plenty. spesestsemperspesestsemper
Comment by spesestsemper on Jul 18, 2024 4:46pm
Not pumping anything professor . Just trying to figure things out .Go back to talking to yourself in your ongoing posts .
Comment by Noteable on Jul 18, 2024 5:01pm
OK. C-YAH
Comment by Noteable on Jul 18, 2024 3:45pm
The $150 Million SFP that was filed on July 12, 2024 is in replacement of the one that expired and was originally filed on June 16, 2022.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities